<DOC>
	<DOCNO>NCT00805519</DOCNO>
	<brief_summary>This study conduct evaluate efficacy safety prednisolone chloroquine add therapy combine glucosamine , chondroitin sulfate osteoarthritis knee do contrast combine glucosamine sulfate chondroitin .</brief_summary>
	<brief_title>Efficacy Safety Prednisolone Chloroquine Add Therapy Osteoarthritis Knee</brief_title>
	<detailed_description>Fixed dose glucosamine , chondroitin sulfate combination treatment osteoarthritis controversy efficacy . seem addition agent may improve efficacy decrease require dose cost . common oral corticosteroid low dose prednisolone chloroquine candidate add therapy . nevertheless , add therapy may expose patient new side effect follow addressed . In investigator blind controlled trial , 240 patient diagnosed osteoarthritis knee enrol study . patient randomly assign one four group G ( glucosamine chondroitin sulfate ) , P ( Glucosamine Chondroitin sulfate plus Prednisolone ) , C ( Glucosamine Chondroitin sulfate plus Chloroquine ) PC ( Glucosamine Chondroitin sulfate plus Prednisolone Chloroquine ) . group consist 60 patient . investigator ( ) blind group intervention .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>men nonpregnant woman , age 4085 year primary OA least one knee . secondary arthritis relate systemic inflammatory arthritis ( include rheumatoid arthritis , psoriatic arthritis , postinfectious arthritis metabolic arthritis , traumatic arthritis surgical joint replacement ) corticosteroid use : oral corticosteroid within previous 14 day intramuscular corticosteroid within 30 day intraarticular corticosteroid study knee within 90 day intraarticular corticosteroid joint within 30 day topical corticosteroid site application within 14 day ongoing use prohibit medication include NSAID , oral analgesic , muscle relaxant , lowdose antidepressant chronic pain management glucosamine chondroitin within previous six month history alcohol drug abuse lactation concomitant skin disease application site current application disability benefit basis knee osteoarthritis ; fibromyalgia ; painful disable condition affect knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Osteoarthritis Knee</keyword>
	<keyword>Glucosamine Chondroitin sulfate</keyword>
	<keyword>Prednisolone</keyword>
	<keyword>Chloroquine</keyword>
</DOC>